Renin–angiotensin system dysregulation in critically ill patients with acute respiratory distress syndrome due to COVID-19: a preliminary report
Open Access
- 1 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 25 (1), 1-3
- https://doi.org/10.1186/s13054-021-03507-7
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock A Clinical TrialAmerican Journal of Respiratory and Critical Care Medicine, 2020
- COVID-19 pneumonia: different respiratory treatments for different phenotypes?Intensive Care Medicine, 2020
- Endothelial cell infection and endotheliitis in COVID-19The Lancet, 2020
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic targetIntensive Care Medicine, 2020
- Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shockCritical Care, 2020
- Pulmonary Capillary Endothelium-Bound Angiotensin-Converting Enzyme Activity in Acute Lung InjuryCirculation, 2000